NCT02125006

Brief Summary

Chronic neuropathic pain is a common problem for breast cancer survivors. Even with the best medical treatment, some survivors continue to experience disabling pain. It is well-established that an interdisciplinary approach is key to the treatment of some types of chronic pain, but little research has been done on the effectiveness of interdisciplinary treatments for cancer survivors with chronic neuropathic pain. The investigators will evaluate the effectiveness of an interdisciplinary approach combining medical treatment and mindfulness-based stress reduction (MBSR) to reduce disability and improve quality of life among breast cancer survivors with chronic neuropathic pain. The investigators will also evaluate the impact of the program on psychological distress, pain cognitions, biomarkers of stress and immune function, cognitive function, as well as brain structure and function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
118

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
Completed

Started Oct 2013

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 23, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 29, 2014

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

July 23, 2019

Status Verified

July 1, 2019

Enrollment Period

4 years

First QC Date

April 23, 2014

Last Update Submit

July 19, 2019

Conditions

Keywords

MindfulnessBreast CancerPainful NeuropathyChronic PainfMRIDisabilityQuality of LifeCytokinesCortisol

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in pain-related disability, as measured by the Brief Pain Inventory - Pain Interference scale, at 3-month post-intervention.

    The primary outcome is pain-related disability, as measured by the Brief Pain Inventory - Pain Interference scale. The Brief Pain Inventory (BPI) - Pain Interference consists of 7 numerical scales (0 to 10) rating pain interference with general activity, mood, walking ability, work, relations with other people, sleep and enjoyment of life.

    Baseline and 3 months post-intervention

Secondary Outcomes (15)

  • Change from baseline in neuropathic pain intensity, as measured by the Neuropathic Pain Symptom Inventory, at 3 months post-intervention

    Baseline and 3 months post-intervention

  • Change from baseline in pain severity, as measured by the Brief Pain Inventory - Pain Severity scale, at 3 months post-intervention

    Baseline and 3 months post-intervention

  • Change from baseline in mood states, as measured by the Profile of Mood States scale, at 3 months post-intervention

    Baseline and 3 months post-intervention

  • Overall change in status from baseline, as measured by Patient Global Impression of Change scale, at 3 months post-intervention

    Baseline and 3 months post-intervention

  • Change from baseline in stress, as measured by the Perceived Stress Scale, at 3 months post-intervention

    Baseline and 3 months post-intervention

  • +10 more secondary outcomes

Study Arms (2)

Interdisciplinary program including MBSR

EXPERIMENTAL

Participants assigned to this group will be enrolled in an Mindfulness-Based Stress Reduction (MBSR) program following medical treatment optimization. The MBSR program will be composed of eight weekly 2.5 hour sessions and one 6 hour session midway through the course.

Behavioral: Mindfulness-Based Stress Reduction

Wait-listed Control Group

NO INTERVENTION

Participants assigned to this group after medical treatment optimization will act as wait-list controls for the MBSR group. They will be enrolled in the MBSR workshop 3 months after the corresponding intervention group completes the program.

Interventions

Consists of eight weekly 2.5 hour sessions and one 6 hour session midway through the course. All sessions will be conducted by a psychologist or social worker with experience in chronic pain, formal MBSR training and 5 years of experience leading MBSR groups. To assess therapist adherence to the protocol, sessions will be recorded. A random selection of 50% of sessions will be rated by an MBSR trainer who completed the University of Massachusetts Centre for Mindfulness in Medicine, Health Care and Society Teacher Development Intensive using a checklist of specified treatment components. A percentage score for each session rated will be calculated to determine therapist adherence.

Interdisciplinary program including MBSR

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female.
  • years or older.
  • Completed treatment for breast cancer a minimum of 1 year prior to study enrollment.
  • Have been experiencing neuropathic pain following their cancer treatment for a minimum of 6 months.
  • Report pain intensity levels ≥4 (moderate to severe).

You may not qualify if:

  • Metastatic disease or current evidence of cancer recurrence
  • Pregnancy or breastfeeding
  • Unable to complete questionnaires in English or French.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ottawa Hospital

Ottawa, Ontario, K1H 8L6, Canada

Location

MeSH Terms

Conditions

Breast NeoplasmsNeuropathy, PainfulChronic PainPain

Interventions

Mindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Patricia Poulin, PhD

    Ottawa Hospital Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2014

First Posted

April 29, 2014

Study Start

October 1, 2013

Primary Completion

October 1, 2017

Study Completion

August 1, 2018

Last Updated

July 23, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations